Slingshot members are tracking this corporate initiative:
Bristol-Myers Squibb (BMY) and Infinity Pharma (INFI) Announce Collaboration Agreement to Study Opdivo and IPI-549 in Patients with Advanced Solid Tumors
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Nov 09, 2016 Projected Implementation: Q4, 2016 Relevance Tracked Until: Q4, 2018
Don’t see a project related to the strategic initiative you care about?
Related Keywords Opdivo, Ipi-549, Advanced Solid Tumors, Collaboration Agreement